Lifeward Ltd.: Business Overview, Financials & Competitive Analysis
Lifeward Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Innovative rehabilitation technology provider with strong revenue growth trajectory and AI integration roadmap, but challenged by small scale and regulatory dependencies. For 2024, Lifeward reported record revenue of $25.7 million (85% increase), driven by strong performance in AlterG Anti-Gravity systems and ReWalk Personal Exoskeleton. The company completed a three-year research.
What is Lifeward Ltd.'s industry? Lifeward Ltd. (golifeward.com) operates in Medical Devices - Rehabilitation Technology & Exoskeletons. AskCyborg classifies Lifeward Ltd. under Medical Devices - Rehabilitation Technology & Exoskeletons in its company registry.
Lifeward is a medical device company that designs, develops, and commercializes technologies enabling mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions. T...
Cyborg Score thesis
Innovative rehabilitation technology provider with strong revenue growth trajectory and AI integration roadmap, but challenged by...
Read the full analyst-debate transcript →Get the Latest Lifeward Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeLifeward Ltd. Overview
Pro stress-test →Lifeward is a medical device company that designs, develops, and commercializes technologies enabling mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions. The company offers ReWalk personal exoskeleton and rehabilitation devices, ReStore soft exo-suit for stroke rehabilitation, AlterG Anti-Gravity System for physical and neurological rehabilitation, MyoCycle devices, and ReBoot personal soft exo-suit for post-stroke use.
Strategic Profile
Pro stress-test →The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024, reflecting its expanded portfolio beyond exoskeletons. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The rebranding positions Lifeward as a comprehensive rehabilitation and recovery solutions provider across clinical and home-use settings.
Competitive Landscape
Pro stress-test →Lifeward competes in the emerging exoskeleton and rehabilitation robotics market. Direct competitors include Myomo (MyoCycle alternatives) and other medical device manufacturers in physical rehabilitation. The market is characterized by high regulatory barriers, significant R&D requirements, and reimbursement challenges from third-party payors. Lifeward's diversified product portfolio spanning exoskeletons, anti-gravity systems, and soft exo-suits provides competitive differentiation.
Industry Context
Lifeward Ltd. operates in Medical Devices - Rehabilitation Technology & Exoskeletons.
Key facts
Founded: 2001 · Headquarters: Yokneam Illit, Israel · Employees: 80 · Revenue: $25.7M (2024) · Market cap: $11.7M